Literature DB >> 15529165

Recombinant protein folding and misfolding in Escherichia coli.

François Baneyx1, Mirna Mujacic.   

Abstract

The past 20 years have seen enormous progress in the understanding of the mechanisms used by the enteric bacterium Escherichia coli to promote protein folding, support protein translocation and handle protein misfolding. Insights from these studies have been exploited to tackle the problems of inclusion body formation, proteolytic degradation and disulfide bond generation that have long impeded the production of complex heterologous proteins in a properly folded and biologically active form. The application of this information to industrial processes, together with emerging strategies for creating designer folding modulators and performing glycosylation all but guarantee that E. coli will remain an important host for the production of both commodity and high value added proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529165     DOI: 10.1038/nbt1029

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  347 in total

1.  Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.

Authors:  Thu Trang Thi Vu; Bon-Kyung Koo; Jung-A Song; Seon-Ha Chong; Cho Rong Park; Minh Tan Nguyen; Boram Jeong; Han-Bong Ryu; Jae Young Seong; Yeon Jin Jang; Robert Charles Robinson; Han Choe
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  Enhanced soluble expression of a thermostable cellulase from Clostridium thermocellum in Escherichia coli.

Authors:  Jingjing Peng; Weiwei Wang; Yuyao Jiang; Mingjie Liu; Hui Zhang; Weilan Shao
Journal:  Curr Microbiol       Date:  2011-09-22       Impact factor: 2.188

3.  Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.

Authors:  Andrezza N Gonçalves; Cesar A Meschiari; William G Stetler-Stevenson; M Cristina Nonato; Cleidson P Alves; Enilza M Espreafico; Raquel F Gerlach
Journal:  J Biotechnol       Date:  2011-10-05       Impact factor: 3.307

4.  Multiple post-translational modifications affect heterologous protein synthesis.

Authors:  Alexander A Tokmakov; Atsushi Kurotani; Tetsuo Takagi; Mitsutoshi Toyama; Mikako Shirouzu; Yasuo Fukami; Shigeyuki Yokoyama
Journal:  J Biol Chem       Date:  2012-06-06       Impact factor: 5.157

Review 5.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

Review 6.  Immunogenicity Risk Assessment for an Engineered Human Cytokine Analogue Expressed in Different Cell Substrates.

Authors:  Paul Chamberlain; Bonita Rup
Journal:  AAPS J       Date:  2020-04-14       Impact factor: 4.009

7.  Magnetic Bead-Immobilized Mammalian Cells Are Effective Targets to Enrich Ligand-Displaying Yeast.

Authors:  Patrick S Lown; Benjamin J Hackel
Journal:  ACS Comb Sci       Date:  2020-04-27       Impact factor: 3.784

8.  The transcriptional response of Escherichia coli to recombinant protein insolubility.

Authors:  Harold E Smith
Journal:  J Struct Funct Genomics       Date:  2007-11-09

9.  Modification in media composition to obtain secretory production of STxB-based vaccines using Escherichia coli.

Authors:  Mohammad Sadraeian; Mohammad Bagher Ghoshoon; Milad Mohkam; Zeinab Karimi; Sara Rasoul-Amini; Younes Ghasemi
Journal:  Virol Sin       Date:  2013-01-17       Impact factor: 4.327

10.  Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.

Authors:  Caslin A Gilroy; Stefan Roberts; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2018-03-15       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.